Human salivary histatins: Promising anti-fungal therapeutic agents

Critical Reviews in Oral Biology and Medicine

Volumn 9, Issue 4, 1998, Pages 480-497

  Tsai, H ^a   Bobek, L A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Anti fungal activity; Anti fungal agents; Candida albicans; Fungal diseases; Histatins

Indexed keywords

HISTATIN;

ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN STABILITY; REVIEW; SALIVA LEVEL; STRAIN DIFFERENCE; VIRULENCE;

EID: 0032319580     PISSN: 10454411     EISSN: None     Source Type: Journal    
DOI: 10.1177/10454411980090040601     Document Type: Review

References (118)

1. Altman-Hamamdzic S, Groseclose C, Ma JX, Hamamdzic D, Vrindavanam NS, Middaugh LD, et al. (1997). Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Ther 4:815-822.
2. Atkinson JC, Wu AJ (1994). Salivary gland dysfunction: causes, symptoms, treatment. J Am Dent Assoc 125:409-416.
3. Atkinson JC, Yeh C, Oppenheim FG, Bermudez D, Baum BJ, Fox PC (1990). Elevation of salivary antimicrobial proteins following HIV-1 infection. J AIDS 3:41-48.
4. Audus KL, Borchardt RT (1991). Transport of macromolecules across the capillary endothelium. In: Targeted drug delivery. Juliano RL, editor. New York: Springer-Verlag, pp. 43-70.
5. Azen EA (1972). Genetic polymorphism of basic proteins from parotid saliva. Science 176:673-674.
6. Azen EA (1973). Properties of salivary basic proteins showing polymorphism. Biochem Genet 9:69-86.
7. Azen EA (1978). Genetic protein polymorphisms in human saliva: an interpretive review. Biochem Genet 16:79-99.
8. Azen EA, Maeda N (1988). Molecular genetics of human salivary proteins and their polymorphisms. Adv Hum Genet 17:141-199.
9. Azen EA, Hellekant G, Sabatini LM, Warner TF (1990). mRNAs for PRPs, statherin, and histatins in von Ebner's gland tissues. J Dent Res 69:1724-1730.
10. Balekjian AY, Longton RW (1973). Histones isolated from human parotid fluid. Biochem Biophys Res Commun 50:676-682.
11. Baum BJ, Bird JL, Millar DB, Longton RW (1976). Studies on histidine-rich polypeptides from human parotid saliva. Arch Biochem Biophys 177:427-436.
12. Baum BJ, Bird JL, Longton RW (1977a). Polyacrylamide gel electrophoresis of human salivary histidine-rich polypeptides. J Dent Res 56:1115-1118.
13. Baum BJ, Ellison SA, Levine MJ (1977b). Differential antigenicity of human salivary histidine-rich polypeptides in goats and rabbits. Arch Oral Biol 22:457-459.
14. Bickel U, Yoshikawa T, Landaw EM, Faull KF, Pardridge WM (1993). Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery. Proc Natl Acad Sci USA 90:2618-2622.
15. Bobek LA, Tsai H, Levine MJ (1993). Expression of human salivary histatin and cystatin/histatin chimeric cDNAs in Escherichia coli. Crit Rev Oral Biol Med 4:581-590.
16. Bonilla CA (1969). Rapid isolation of basic proteins and polypeptides from salivary gland secretions by chromatography on polyacrylamide gel. Anal Biochem 32:522-529.
17. Brant EC, Santarpia RP III, Pollock JJ (1990). The role of pH in salivary histidine-rich polypeptide anti-fungal germ tube inhibitory activity. Oral Microbiol Immunol 5:336-339.
18. Budtz-Jørgensen E (1974). The significance of Candida albicans in denture sore mouth. Scand J Dent Res 82:151-190.
19. Budtz-Jørgensen E (1990). Candida-associated denture stomatitis and angular cheilitis. In: Oral candidosis. Samaranayake LP, MacFarlane TW, editors. London: Butterworth, pp. 156-183.
20. Cannon RD, Holmes AR, Mason AB, Monk BC (1995). Oral candida: clearance, colonization, or candidiasis? J Dent Res 74:1152-1161.
21. Colon JO, Xu T, Oppenheim FG (1993). Bactericidal effect of salivary histatin-5 on Porphyromonas gingivalis (abstract). J Dent Res 72(Spec Iss):322.
22. Connelly S, Gardner JM, McClelland A, Kaleko M (1996). High-level tissue-specific expression of functional human factor VIII in mice. Hum Gene Ther 7:183-195.
23. Dickinson DP, Ridall AL, Levine MJ (1987). Human submandibular gland statherin and basic histidine-rich peptide are encoded by highly abundant mRNAs derived from a common ancestral sequence. Biochem Biophys Res Commun 149:784-790.
24. Driscoll J, Zuo Y, Xu T, Choi JR, Troxler RF, Oppenheim FG (1995). Functional comparison of native and recombinant human salivary histatin 1. J Dent Res 74:1837-1844.
25. Driscoll J, Duan C, Zuo Y, Xu T, Troxler R, Oppenheim FG (1996a). Candidacidal activity of human salivary histatin recombinant variants produced by site-directed mutagenesis. Gene 177:29-34.
26. Driscoll J, Zuo Y, Xu T, Troxler RF, Oppenheim FG (1996b). Investigation of the anti-candidal mechanism of histatins (abstract). J Dent Res 75(Spec Iss):358.
27. Driscoll J, Xu T, Oppenheim FG (1997). Histatins: structure, function, and genetics. In: Studies in stomatology and craniofacial biology. Cohen MM, Baum BJ, editors. Amsterdam, The Netherlands: IOS Press, pp. 445-460.
28. Edgerton M, Lo SE, Levine MJ (1993). Histatins induce leakage from C. albicans cells and model liposome membrane (abstract). J Dent Res 72(Spec Iss):322.
29. Edgerton M, Raj PA, Levine MJ (1995). Surface-modified poly(methyl methacrylate) enhances adsorption and retains anti-candidal activities of salivary histatin 5. J Biomed Mater Res 29:1277-1286.
30. Edgerton M, Lo T, Raj PA (1996). Salivary histatin-3 and histatin-5 exhibit specific binding to yeast cell membranes (abstract). J Dent Res 75(Spec Iss):358.
31. Epstein JB, Freilich MM, Le ND (1993). Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol 76:169-174.
32. Garg AK, Malo M (1997). Manifestation and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy. J Am Dent Assoc 128:1128-1133.
33. Georgopapadakou NH, Walsh TJ (1996). Anti-fungal agents: chemotherapeutic targets and immunologic strategies; minireview. Antimicrob Agents Chemother 40:279-291.
34. Hawkins C, Armstrong D (1984). Fungal infections in the immunocompromised host. Clin Haematol 13:599-630.
35. Hay DI (1975). Fractionation of human parotid salivary proteins and the isolation of an histidine-rich acidic peptide which shows high affinity for hydroxyapatite surfaces. Arch Oral Biol 20:553-558.
36. Holbrook IB, Molan PC (1975). The identification of a peptide in human parotid saliva particularly active in enhancing the glycolytic activity of the salivary microorganisms. Biochem J 149:489-492.
37. Jensen JL, Xu T, Lamkin MS, Brodin P, Aars H, Berg T, et al. (1994). Physiological regulation of the secretion of histatins and statherins in human parotid saliva. J Dent Res 73:1811-1817.
38. Joly V, Bolard J, Yeni P (1992). In vitro models for studying toxicity of anti-fungal agents. Antimicrob Agent Chemother 36:1799-1804.
39. Kagami H, O'Connell BC, Baum BJ (1996). Evidence for the systemic delivery of a transgene product from salivary glands. Hum Gene Ther 7:2177-2184.
40. Kalpidis CD, Xu T, Oppenheim FG (1992). Effects of human salivary histatin-5 on Actinomyces species (abstract). J Dent Res 71(Spec Iss):305.
41. Kalpidis CD, Xu T, Murakami Y, Oppenheim FG (1995). Inhibition of Bacteroides forsythus hemagglutination by human salivary histatins (abstract). J Dent Res 74(Spec Iss):123.
42. Kato T, Takahashi N, Kuramitsu H (1992). Sequence analysis and characterization of the Porphyromonas gingivalis prtC gene, which expresses a novel collagenase activity. J Bacteriol 174:3889-3895.
43. Koshlukova S, Lo T, Chrzan B, Edgerton M (1997). Histatin interaction with Candida albicans envelope protein is related to candidacidal activity (abstract). J Dent Res 76(Spec Iss):296.
44. Lachmann RH, Efstathiou S (1997). The use of herpes simplex virus-based vectors for gene delivery to the nervous system. Mol Med Today 3:404-411.
45. Lal K, Pollock JJ, Santarpia RP III, Heller HM, Kaufman HW, Fuhrer J, et al. (1992a). Pilot study comparing the salivary cationic protein concentration in healthy adults and AIDS patients: correlation with anti-fungal activity. J Acquir Immune Defic Syndr 5:904-914.
46. Lal K, Santarpia RP III, Xu L, Manssuri F, Pollock JJ (1992b). One-step purification of histidine-rich polypeptides from human parotid saliva and determination of anti-candidal activity. Oral Microbiol Immunol 7:44-50.
47. Lal K, Xu L, Colburn J, Hong AL, Pollock JJ (1992c). The use of capillary electrophoresis to identify cationic proteins in human parotid saliva. Arch Oral Biol 37:7-13.
48. Lamkin MS, Oppenheim FG (1993). Structural features of salivary function. Crit Rev Oral Biol Med 4:251-259.
49. MacKay BJ, Pollock JJ, Iacono VJ, Baum BJ (1984a). Isolation of milligram quantities of a group of histidine-rich polypeptides from human parotid saliva. Infect Immun 44:688-694.
50. MacKay BJ, Denepitiya L, Iacono VJ, Krost SB, Pollock JJ (1984b). Growth-inhibitory and bactericidal effects of human parotid salivary histidine-rich polypeptides on Streptococcus mutans. Infect Immun 44:695-701.
51. Mandel ID, Barr CE, Turgeon L (1992). Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 21:209-213.
52. Mitchell TG, Perfect JR (1995). Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8:515-548.
53. Murakami Y, Takeshita T, Shizukuishi S, Tsunemitsu A, Aimoto S (1990). Inhibitory effects of synthetic histidine-rich peptides on haemagglutination by Bacteroides gingivalis 381. Arch Oral Biol 35:775-777.
54. Murakami Y, Nagata H, Amano A, Takagaki M, Shizukuishi S, Tsunemitsu A, et al. (1991a). Inhibitory effects of human salivary histatins and lysozyme on coaggregation between Porphyromonas gingivalis and Streptococcus mitis. Infect Immun 59:3284-3286.
55. Murakami Y, Shizukuishi S, Tsunemitsu A, Nakashima K, Kato Y, Aimoto S (1991b). Binding of a histidine-rich peptide to Porphyromonas gingivalis. FEMS Microbiol Lett 82:253-256.
56. Murakami Y, Nagata H, Shizukuishi S, Nakashima K, Okawa T, Takigawa M, et al. (1994). Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation. Biochem Biophys Res Commun 198:274-280.
57. Murakami Y, Xu T, Oppenheim FG (1995). Inhibitory effect of histatin-5 on leukotoxin from Actinobacillus actinomycetemcomitans (abstract). J Dent Res 74(Spec Iss):123.
58. Naffakh N, Pinset C, Montarras D, Li S, Paulin D, Danos O, et al. (1996). Long-term secretion of therapeutic proteins from genetically modified skeletal muscles. Hum Gene Ther 7:11-21.
59. Nishikata M, Kanehira T, Oh H, Tani H, Tazaki M, Kubo Y (1991). Salivary histatin as an inhibitor of a protease produced by the oral bacterium Bacteroides gingivalis. Biochem Biophys Res Commun 174:625-630.
60. O'Connell BC, Baum BJ (1997). Gene transfer to salivary glands. In: Studies in stomatology and craniofacial biology. Cohen MM, Baum BJ, editors. Amsterdam, The Netherlands: IOS Press, pp. 615-631.
61. O'Connell BC, Xu T, Walsh TJ, Sein T, Mastrangeli A, Crystal RG, et al. (1996). Transfer of a gene encoding the anti-candidal protein histatin 3 to salivary glands. Hum Gene Ther 7:2255-2261.
62. Odds FC (1988). Candida and candidosis: a review and bibliography. 2nd ed. London, UK: Bailliere Tindall.
63. Oppenheim FG, Yang YC, Diamond RD, Hyslop D, Öffner GD, Troxler RF (1986). The primary structure and functional characterization of the neutral histidine-rich polypeptide from human parotid secretion. J Biol Chem 261:1177-1182.
64. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Öffner GD, et al. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion. J Biol Chem 263:7472-7477.
65. Palmer TD, Thompson AR, Miller AD (1989). Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 73:438-445.
66. Pals G, Pronk JC (1979). Genetic variation in parotid basic proteins (Pb) in the Bozo (Mali, West Africa). Hum Genet 49:355-359.
67. Pannuti CS, Gingrich R, Pfaller MA, Kao C, Wenzel RP (1992). Nosocomial pneumonia in patients having bone marrow transplant. Cancer 69:2653-2662.
68. Paquette DW, Waters GS, Stefanidou VL, Lawrence HP, Friden PM, O'Connor SM, et al. (1997). Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins. J Clin Periodontol 24:216-222.
69. Parvinen T, Larmas M (1981). The relation of stimulated salivary flow rate and pH to lactobacillus and yeast concentrations in saliva. J Dent Res 60:1929-1935.
70. Payne JB, Iacono VJ, Crawford IT, Lepre BM, Bernzweig E, Grossbard BL (1991). Selective effects of histidine-rich polypeptides on the aggregation and viability of Streptococcus mutans and Streptococcus sanguis. Oral Microbiol Immunol 6:169-176.
71. Peters EH, Goodfriend T, Azen EA (1977). Human Pb, human post-Pb, and nonhuman primate Pb proteins: immunological and biochemical relationships. Biochem Genet 15:947-963.
72. Peterson DE (1992). Oral candidiasis. Clin Geriat Medi 8:513-527.
73. Polak A (1989). Combinations therapy for systemic mycosis. Infection 17:203-209.
74. Pollock JJ, Denepitiya L, MacKay BJ, Iacono VJ (1984). Fungistatic and fungicidal activity of human parotid salivary histidine-rich polypeptides on Candida albicans. Infect Immun 44:702-707.
75. Pronk JC, Jansen WJ, Pronk A, vdPol CFAM, Frants RR, Eriksson AW (1984). Salivary protein polymorphism in Kenya: evidence for a new AMY1 allele. Hum Hered 34:212-216.
76. Raj PA, Edgerton M, Levine MJ (1990). Salivary histatin-5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem 265:3898-3905.
77. Raj PA, Soni SD, Levine MJ (1994). Membrane-induced helical conformation of an active candidacidal fragment of salivary histatins. J Biol Chem 269:9610-9619.
78. Raj PA, Marcus E, Sukumaran DK (1998). Structure of human salivary histatin 5 in aqueous and non-aqueous solutions. Biopolymers 45:51-67.
79. Ramalingam K, Gururaja TL, Ramasubbu N, Levine MJ (1996). Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity. Biochem Biophys Res Commun 225:47-53.
80. Rayhan R, Xu L, Santarpia RP III, Tylenda CA, Pollock JJ (1992). Anti-fungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates. Oral Microbiol Immunol 7:51-52.
81. Robinson DH, Mauger JW (1991). Drug delivery systems. Am J Hosp Pharm 48:S14-S23.
82. Rosenfeld MA, Siegfried W, Yoshimura K, Yoneyama K, Fukuyama M, Stier LE, et al. (1991). Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 252:431-434.
83. Sabatini LM, Azen EA (1989). Histatins, a family of salivary histidine-rich proteins, are encoded by at least two loci (HIS1 and HIS2). Biochem Biophys Res Commun 160:495-502.
84. 2 allele characterize the salivary histatin 3-2 protein variant. Hum Mutat 4:12-19.
85. Sabatini LM, Warner TF, Saitoh E, Azen EA (1989). Tissue distribution of RNAs for cystatins, histatins, statherin, and proline-rich salivary proteins in humans and Macaques. J Dent Res 68:1138-1145.
86. Sabatini LM, Ota T, Azen EA (1993). Nucleotide sequence analysis of the human salivary protein genes HIS1 and HIS2, and evolution of the STATH/HIS gene family. Mol Biol Evol 10:497-511.
87. 1-40/vector complex. Proc Natl Acad Sci USA 92:10227-10231.
88. Samaranayake LP, McCourtie J, MacFarlane TW (1980). Factors affecting the in vitro adherence of Candida albicans to acrylic surfaces. Arch Oral Biol 25:611-615.
89. Santarpia RP III, Brant EC, Lal K, Brasseur MM, Hong AL, Pollock JJ (1988). A comparison of the inhibition of blastospore viability and germ-tube development in Candida albicans by histidine peptides and ketoconazole. Arch Oral Biol 33:567-573.
90. Santarpia RP III, Cho MI, Pollock JJ (1990). Parameters affecting the inhibition of Candida albicans GDH2023 and GR12773 blastospore viability by purified synthetic salivary histidine-rich polypeptides. Oral Microbiol Immunol 5:226-232.
91. Santarpia RP III, Pollock JJ, Renner RP, Gwinnett AJ (1991). In vivo anti-fungal efficacy of salivary histidine-rich polypeptides: preliminary finding in a denture stomatitis model system. J Prosthet Dent 66:693-699.
92. Sayani AP, Chien YW (1996). System delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Sys 13:85-184.
93. Shrestha P, Hashimoto J, Takagi H, Yamada K, Mori M, Kanehira T, et al. (1994). Immunoreactive histatin 5 in salivary gland tumors. Acta Histochem Cytochem 27:527-534.
94. Smith DB, Johnson KS (1988). Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
95. Sternberg S (1994). The emerging fungal threat. Science 266:1632-1634.
96. Suddick RP, Hyde RJ, Feller RP (1980). Salivary water and electrolytes and oral health. In: The biological basis of dental caries, an oral biology textbook. Menaker L, editor. Hagerstown, MD: Harper & Row Publishers, Inc., pp. 132-147.
97. Sugiyama K (1993). Anti-lipopolysaccharide activity of histatins, peptides from human saliva. Experientia 49:1095-1097.
98. Sugiyama K, Ogata K (1993). High-performance liquid chromatographic determination of histatins in human saliva. J Chromatogr 619:306-309.
99. Sugiyama K, Suzuki Y, Furuta H (1985). Isolation and characterization of histamine-releasing peptides from human parotid saliva. Life Sci 37:475-480.
100. Troxler RF, Öffner GD, Xu T, VanderSpek JC, Oppenheim FG (1990). Structural relationship between human salivary histatins. J Dent Res 69:2-6.
101. Tsai H (1997). Structure-function studies of human salivary histatins with respect to their candidacidal activity (dissertation). Buffalo, NY: State Univ. of New York.
102. Tsai H, Bobek LA (1997a). Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans (rapid report). Biochim Biophys Acta 1336:367-369.
103. Tsai H, Bobek LA (1997b). Studies on the mechanism of human salivary histatin-5 cidal activity using histatin-5 variants and azole-sensitive and -resistant Candida species. Antimicrob Agents Chemother 41:2224-2228.
104. Tsai H, Raj PA, Bobek LA (1996). Candidacidal activity of recombinant human salivary histatin-5 and variants. Infect Immun 64:5000-5007.
105. Tsai H, Raj PA, Bobek LA (1997). Candidacidal activity and helical conformation of active C-terminal fragments of human salivary histatin-5. Int J Oral Biol 22:67-71.
106. Tsuchida S, Ikemoto S (1989). Further studies of salivary polymorphisms in the Japanese population. Hum Hered 39:61-66.
107. Vanden Bossche H, Willemsens G, Marichal P (1987). Anti-candida drugs - The biochemical basis for their activity. CRC Crit Rev Microbiol 15:57-72.
108. Vanden Bossche H, Warnock DW, Dupont B, Kerridge D, Sen Gupta S, Improvisi L, et al. (1994). Mechanisms and clinical impact of anti-fungal drug resistance. J Med Vet Mycol 32(Suppl 1):189-202.
109. VanderSpek JC, Wyandt HE, Skare JC, Milunsky A, Oppenheim FG, Troxler RF (1989). Localization of the genes for histatins to human chromosome 4q13 and tissue distribution of the mRNA. Am J Hum Genet 45:381-387.
110. VanderSpek JC, Öffner GD, Troxler RF, Oppenheim FG (1990). Molecular cloning of human submandibular histatins. Arch Oral Biol 35:137-143.
111. Xu L, Lal K, Pollock JJ (1992). Histatins 2 and 4 are autoproteolytic degradation products of human parotid saliva. Oral Microbiol Immunol 7:127-128.
112. Xu L, Lal K, Santarpia RP III, Pollock JJ (1993). Salivary proteolysis of histidine-rich polypeptides and the anti-fungal activity of peptide degradation products. Arch Oral Biol 38:277-283.
113. Xu T, Oppenheim FG (1993). Salivary antimicrobials: where are we? Ann NY Acad Sci 694:117-131.
114. Xu T, Levitz SM, Diamond RD, Oppenheim FG (1991). Anti-candidal activity of major human salivary histatins. Infect Immun 59:2549-2554.
115. Xu T, Kalpidis CD, Oppenheim FG (1995). Effects of human salivary histatins on Streptococcus rattus glycolysis (abstract). J Dent Res 74(Spec Iss):122.
116. Yan Q, Bennick A (1995). Identification of histatins as tannin-binding proteins in human saliva. Biochem J 311:341-347.
117. Zegarelli EV, Kutscher AH, Herlands RE, Lucca JJ, Silvers HF (1961). Oral lesions of interest to the prosthodontist. Part I, denture stomatitis. J Prosthet Dent 11:617-620.
118. Zuo Y, Xu T, Troxler RF, Li J, Driscoll J, Oppenheim FG (1995). Recombinant histatins: functional domain duplication enhances candidacidal activity. Gene 161:87-91.